Aromasin vs. Arimidex: Comparing Top Treatments for Breast Cancer
Aromasin and Arimidex are used in treating hormone-receptor-positive breast cancer in postmenopausal women. They are aromatase inhibitors, reducing estrogen production to slow cancer growth. Aromasin (exemestane) often follows tamoxifen therapy, while Arimidex (anastrozole) may be used first-line. Both drugs, differing in structure, are chosen based on individual health, cancer stage, and treatment response. Common side effects include joint pain and fatigue. These medications have improved breast cancer outcomes, highlighting personalized therapy’s significance.

